Meeting the urgent need for new antibiotics
Stevenage, United Kingdom
< 10 Employees
High Level Pitch
Auspherix’ pre-clinical R&D programmes are based on its discovery of antibacterials with a unique profile. These proprietary compounds have demonstrated activity against a broad range of important multidrug resistant (MDR) Gram-negative and Gram-positive bacterial strains. We intend to develop and license these novel antibiotic drug candidate molecules to pharmaceutical companies with expertise in the anti-infective space.